JPRN-UMIN000001478
Completed
未知
A combination of cinacalcet with maxacalcitol for regression of moderate to advanced secondary hyperparathyroidism in patients on chronic hemodialysis - Combined therapy of cinacalcet with maxacalcitol for regression of secondary hyperparathyroidism
Kitano Hospital Division of Nephrology and Dialysis0 sites50 target enrollmentOctober 25, 2009
Conditionssecondary hyperparathyroidism
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- secondary hyperparathyroidism
- Sponsor
- Kitano Hospital Division of Nephrology and Dialysis
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Uncontrolled ischemic heart disease, heart failure, and arrhythmia 2\) Stroke within 6 months 3\) Peripheral artery didease of Fontaine 3 and 4 4\) Severe liver cirrhosis 5\) Malignancy within 3 years 6\) Uncontrolled phychosis 7\) Attendant for other clinical studies within 3 months 8\) Pregnant woman or man who wish for baby 9\) Unsuitable patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Cinacalcet for the treatment of hypercalcemia with persistent hyperparathyroidism in renal transplant recipients: a case siries study.Hypercalcemia with persistent hyperparathyroidism in renal transplant recipients.JPRN-UMIN000003236St Marianna University15
Completed
Not Applicable
Cinacalcet and concurrent intravenous calcitriol for treatment of secondary hyperparathyroidism in dialysis patients compared with intravenous calcitriol alonesecondary hyperparathyroidismJPRN-UMIN0000034381.Division of Internal medicine, Seseragi hospital 2.Department of Medicine & Biological Science Gunma University Graduate School of Medicine100
Completed
Phase 4
Efficacy and safety of treatment with Cinacalcet in patients with Primary Hyperparathyroidism due to a MEN-1 mutatiohyperactive parathyroid glandsprimary hyperparathyroidism1008362410033949NL-OMON34871eids Universitair Medisch Centrum20
Active, not recruiting
Not Applicable
Assess the stability / benefit of Cinacalcet treatment over conventional therapy based on bone metabolism, arterial stiffness and vascular calcification in advanced chronic renal failureBone's disorders and mineral metabolism and vascular involvementMedDRA version: 16.1Level: PTClassification code 10051753Term: Vascular calcificationSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Body processes [G] - Metabolic Phenomena [G03]EUCTR2013-002270-52-ESHospital Universitari de Girona Dr.Josep Trueta
Active, not recruiting
Not Applicable
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPTPatients with primary hyperparathyroidism due to a germline mutation in the MEN-1 geneMedDRA version: 12.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismEUCTR2010-018861-53-NLeiden University Medical Center